The Noninvasive Ventilation to COVID-19 Patients

NCT04568655 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2020-09-29

No results posted yet for this study

Summary

Noninvasive ventilation(NIV) is an important treatment to the respiratory failure patients.The severe Corona Virus Disease-19(COVID-19) patients are incline to respiratory failure.The NIV may reduce the intubtion rate.This research was taken to investigate the factor to the success of the noninvasive ventilation to the COVID-19 patients with respiratory failure.

Conditions

  • Noninvavie Ventilation to Patients With COVID-19

Interventions

DEVICE

noninvasive ventilation

noninvasive ventilation to support the COVID-19 patients with respiratory failure

Sponsors & Collaborators

  • The First Affiliated Hospital of Guangzhou Medical University

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2020-07-01
Completion
2020-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04568655 on ClinicalTrials.gov